Navigation Links
Rigel To Focus On ITP, DLE And Dry Eye
Date:9/5/2013

ucturing and other charges associated with this measure, which are expected to be recorded predominantly in the third quarter of 2013.  As of June 30, 2013, the company had $251 million in cash and equivalents, which Rigel believes is enough to maintain its current development priorities into 2016.

Rigel remains committed to its mission to identify and develop novel small molecule therapeutics and will maintain active programs including:  R118, an oral AMPK activator being developed as a potential treatment for intermittent claudication (peripheral artery disease).

Immune Thrombocytopenic Purpura (ITP)

Chronic ITP affects approximately 100,000 people, with the majority of these cases being in women. ITP is a blood disorder in which the immune system attacks and destroys the body's own blood platelets, which have an important role in the clotting and healing process.  ITP patients can suffer bruising, bleeding and fatigue as a result of their low blood platelet counts.  Currently marketed therapies aim to raise blood platelet counts, but do not address the etiology of the disorder.  The results of Rigel's Phase 2 study, published in Blood (volume 113, number 14), showed that fostamatinib may be effective in treating this rare autoimmune disorder.

Discoid Lupus Erythematosus (DLE)

DLE is a chronic autoimmune disease of the skin, which affects approximately 300,000 Americans - with an estimated 16,000 additional new cases diagnosed in the US each year.  Disc-shaped sores with inflammation, swelling, scaling, scarring, pigment discoloration, and even hair loss characterize the disease. The lesions most commonly appear in sun-exposed areas, predominantly on the face, chest and scalp. Rigel's R333 is a potent, topical JAK and SYK inhibitor that is designed to interrupt pivotal inflammatory cascade signals with the potential to prevent or diminish both acute and chronic symptoms. Result
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Rigel to Present at BIO CEO & Investor Conference
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
11. Rigel Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015   Americord ... tissue , and placenta tissue banking company, announced ... the 2015 Inc. 500. Logo - http://photos.prnewswire.com/prnh/20150902/263095LOGO ... companies, honorees had to have grown at least tenfold over ... since 2011 and has continued this trend with 50% quarterly ...
(Date:9/2/2015)... SHENZHEN, China, Sept. 2, 2015 China Nepstar ... the "Company"), a leading retail drugstore chain in China ... announced its unaudited financial results for the second quarter ... quarter ended June 30, 2015: , Revenue increased ... RMB686.6 million in the second quarter of 2014 ...
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
Breaking Medicine Technology:Americord Registry Announces Ranking on 2015 Inc. 500 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results 10Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2
... May 15, 2012  Today, leading events organizer UBM ... North America,s leading networking event for buyers and sellers ... participation at the flagship show which takes place from ... Convention Center, Anaheim, CA. Major pharmaceutical, fine and specialty ...
... Inc. ( www.pneumrx.com ), a medical device company dedicated ... lung disease, today announced that it has received FDA ... support a PMA application for the RePneu LVRC System. ... RePneu LVRC System is a minimally invasive device intended ...
Cached Medicine Technology:Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System 2PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System 3
(Date:9/2/2015)... ... September 02, 2015 , ... Alameda County Community Food Bank ... Month” during the entire month of September. In the spirit of the ... efforts this September to an awareness campaign educating legislators and the public on ...
(Date:9/2/2015)... Beach, Calif. (PRWEB) , ... September 02, 2015 ... ... injection therapy clinic combining both naturopathic and allopathic medicine, opens its second location ... The new clinic features roughly 1000 square feet of lounge space for patients ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... at Children's Healthcare of Atlanta to help support childhood cancer research. On ... upcoming WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors ...
(Date:9/2/2015)... KY (PRWEB) , ... September 02, 2015 , ... Ericson ... the CDI Education Director for HCPro and Associate Director of Education for the Association ... CDI, Advancing CDI and ICD-10 for CDI Boot Camps. She serves as a CDI ...
(Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
Breaking Medicine News(10 mins):Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4
... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
Medicine Products: